Tag Directory / SUPPLYCHAIN     showing 1–20 of 28   RSS



How Cyclospora Evaded the U.S. Food Safety System to Sicken Thousands

Christina Jewett and Julie Creswell / nytimes - The Trump administration delayed a rule last year that could have sped up the effort to pinpoint the source of the contamination. Critics charge that food safety oversight has eroded overall.

AI Summary: An extensive Cyclospora outbreak has sickened thousands, revealing how fecal contamination slipped into the food chain and into public health blind spots. Investigations point to the parasite’s movement through human waste and lapses in detection and prevention, prompting renewed scrutiny of inspection systems and calls for tighter controls to stop another avoidable wave.

13 days / medicalxpress

19 days / medicalxpress




Health IT Vendor’s Data Breach Exposes Nearly 4M Patient Records

Katie Adams / medcitynews - Revenue cycle vendor Unlimited Technology Systems disclosed a ransomware attack affecting 3.8 million patients — the second-largest healthcare data breach reported to HHS this year.The post Health IT Vendor’s Data Breach Exposes Nearly 4M Patient Records …

AI Summary: A ransomware attack on a health IT vendor exposed nearly four million patient records, prompting urgent security reviews and fresh scrutiny of vendor controls. The incident highlights systemic vulnerabilities in healthcare data protections, spurred regulatory attention and calls for tighter oversight across third‑party technology providers.




Fridge-free tetanus-diphtheria vaccine shows promise of reaching millions worldwide

medicalxpress - The encouraging results of the world's first trial of a fridge-free tetanus-diphtheria vaccine could improve access worldwide to crucial treatments while reducing carbon emissions. Fridge-free vaccines have the potential to transform vaccine delivery by r…

AI Summary: Early studies of fridge‑free vaccine formulations, including a tetanus‑diphtheria candidate, indicate stability without cold storage, promising to reduce discarded doses and simplify distribution in low‑resource settings. If these results hold up, the change could shrink logistical headaches, boost global immunization reach and finally make the vaccine refrigerator’s light a little less terrifying.

9 days / medicalxpress

12 days / medicalxpress

23 days / medicalxpress

24 days / bbc




FDA approves Moderna’s mRNA flu vaccine

Ella Jeffries / beckershospitalreview - The FDA has approved Moderna’s mFLUSIVA (mRNA-1010), the first mRNA-based influenza vaccine in the U.S., for the prevention of seasonal influenza in adults ages 50 and older. The decision follows a monthslong regulatory process that included the agency’s …

AI Summary: The FDA has approved Moderna's mRNA flu vaccine, giving the familiar seasonal bug a high-tech reboot. Regulators cleared Moderna’s mRNA formulation for public use, signaling a shift toward next-generation influenza vaccines; rollout details, target groups and supply plans will follow as public health authorities coordinate distribution for the coming flu season.


FDA's reversal and approval of Moderna mRNA flu shot

23 days / livescience

24 days / medicalxpress


Public health guidance and flu season preparedness

15 days / medicalxpress

16 days / medicalxpress

19 days / medicalxpress


What mFLUSIVA approval means for policy, coverage and mRNA

19 days / livescience




HHS announces decertification of Kentucky-based organ procurement organization Network for Hope

fiercehealthcare - HHS Secretary Robert F. Kennedy Jr. said the decertification comes after federal reviews found “persistent patient safety failures.”

AI Summary: Federal health officials moved to decertify Network for Hope, a Kentucky-based organ procurement organization, after finding systemic safety and performance failures. The decision severs federal ties, triggers oversight and potential restructuring, and raises immediate questions about organ recovery operations and transplant continuity in the affected region. Bureaucracy meets blunt enforcement — inconvenient but necessary.

24 days / abcnews




American Red Cross declares second-ever national blood supply crisis, urges ‘immediate’ donations

fiercehealthcare - Donations this summer are not “keeping pace with hospital demand,” with the non-profit citing extreme heat, poor air quality and foodborne illnesses as factors in the low donor turnout.

AI Summary: The American Red Cross has declared a rare national blood supply crisis and issued an urgent plea for donors as reserves plunged during summer shortages. Officials warned hospitals may face delays for transfusions and called for immediate donations across all blood types to avert disruptions to routine and emergency care.

28 days / oncodaily




As Cyclospora Cases Climb, FDA Official Says Food Supply Is Safe

Julie Creswell / nytimes - The acting deputy commissioner for food said the agency was taking action even though finding the root cause of the outbreaks is difficult.

AI Summary: Health authorities are tracking a rising number of cyclospora infections while stressing the overall safety of the food supply. Officials urged vigilance and proper food handling, noting some patients experience severe gastrointestinal illness. Public health experts warned that recurring outbreaks raise concerns about vulnerabilities in produce safety and monitoring systems.


Iceberg lettuce link: multistate traceback and restaurant impacts

24 days / medicalxpress

24 days / abcnews

4 wks / abcnews


Public health strain: FDA reassures, experts warn, symptoms and travel

4 wks / bbc


Scope and toll: exploding cases, hospitalizations and first U.S. deaths

25 days / bbc

26 days / livescience

26 days / medicalxpress


All Other Stories

22 days / kffhealthnews

23 days / medicalxpress




1.6 Million Egg Cartons Are Recalled Over Salmonella Risk

Alena Cerro / nytimes - The voluntary recall included eggs produced in Texas and sold under several brand names in six states, the Food and Drug Administration said.

AI Summary: The USDA-ordered recall removes roughly 1.6 million cartons (about 1.6 million dozen) of eggs after Salmonella contamination concerns surfaced. Retailers have been instructed to pull affected lots and consumers advised to discard or return suspect products. Regulators and producers are scrambling to trace the source and contain potential outbreaks.




Taylor Farms Expands Iceberg Lettuce Recall to 27 States Amid Cyclospora Outbreak

Christina Jewett and Julie Creswell / nytimes - The implicated products were marketed under several brands, and had been shipped as recently as Thursday.

AI Summary: Taylor Farms has widened an iceberg-lettuce recall to 27 states after a Cyclospora outbreak sickened consumers. Health officials are urging anyone who purchased affected product to discard it and seek medical care if symptoms appear, while investigators trace distribution channels to pinpoint the contamination source. Yes, the lettuce did more than just wilt.


FDA retraction and ongoing source investigations


Outbreak scale and clinical testing surge

5 wks / livescience


Taylor Farms recall, company fallout and political scrutiny




Hospital groups, GPO push back on CMS’ 2027 outpatient rule

Ella Jeffries / beckershospitalreview - Four groups are condemning CMS’ proposed 2027 Hospital Outpatient Prospective Payment System and Ambulatory Surgery Center rule, which would cut what Medicare pays hospitals for 340B drugs and expand site-neutral payments into a new category of services. …

AI Summary: Major hospital groups and purchasing GPOs are pushing back on CMS’ proposed 2027 outpatient payment rule, warning that reimbursement changes could disrupt provider margins, patient access and group purchasing dynamics. CMS’ proposal would alter outpatient payment calculations; hospitals argue the revisions threaten financial viability of some outpatient services and request policy rework and deeper stakeholder engagement.


Broader CMS 2027 payment changes: physician cuts and RPM ban


Hospitals and GPOs push back on 340B, site-neutral OPPS

1 month / oncodaily


Rural and vulnerable hospitals warn of closures, wider deficits




Orca Bio Cell Therapy Gets Landmark FDA Nod for New Kind of Living Medicine

Frank Vinluan / medcitynews - FDA approval of Orca Bio’s Tregzi makes it the first cell therapy based on regulatory T cells, or Tregs. Clinical trial results showed reduced risk of graft-versus-host disease, a common complication of the allogeneic stem cell transplants that are a stan…

AI Summary: Orca Bio’s off‑the‑shelf allogeneic cell therapy received FDA approval, marking a milestone for engineered living medicines. Regulators cleared the product after pivotal efficacy and manufacturing data, offering broader access to cellular therapy but spotlighting cost, supply logistics and the need for robust post‑market safety surveillance.

1 month / oncodaily




Cancer drug shortage renews calls for federal action

medicalxpress - Cancer doctors across the United States are running short of essential generic chemotherapy drugs, and some fear the squeeze could force widespread rationing, The New York Times reported.

AI Summary: Hospitals and oncology clinics are facing critical shortages of key chemotherapy agents, forcing clinicians to consider rationing or alternative regimens. The supply squeeze has reignited demands for federal intervention, supply‑chain fixes, and clearer contingency plans to protect patients who can’t exactly wait for bureaucratic miracles.

2 months / medicalxpress




E. Anders Kolb: Blood Cancer United Preserves Access to Luveltamab Tazevibulin for Children with AML

oncodaily - E. Anders Kolb, Chief Executive Officer of Blood Cancer United, shared a post on LinkedIn: “Today we announced a first‑of‑its‑kind intervention from a nonprofit. Blood Cancer United has stepped up […]

AI Summary: A nonprofit stepped into a supply crisis and purchased the remaining stock of an experimental agent to preserve access for children with acute myeloid leukemia. The emergency buy protects current patients from treatment interruption while stakeholders scramble for a durable manufacturing or regulatory fix, illustrating how charities sometimes act like pharma’s safety net.

2 months / medicalxpress

2 months / oncodaily

2 months / oncodaily




Congo's Ebola outbreak rises to 100 deaths out of 550 cases after a month

abcnews - At least 100 people have died from Ebola less than a month after authorities declared an outbreak of the disease in eastern Congo

AI Summary: An Ebola outbreak in Central Africa has crossed the 100‑death threshold, with cases rising faster than response measures. Public‑health experts warn vaccines alone won’t halt spread and modelling cautions that, without stronger surveillance, contact tracing and community engagement, the epidemic could grow dramatically. Global vaccine efforts are racing to catch up.

2 months / abcnews

2 months / medicalxpress

2 months / medicalxpress

2 months / medicalxpress

2 months / medicalxpress

2 months / medicalxpress

2 months / medicalxpress

2 months / medicalxpress

2 months / bbc

2 months / abcnews

2 months / medicalxpress

2 months / medicalxpress

2 months / medicalxpress

2 months / abcnews

2 months / livescience

2 months / abcnews

2 months / medicalxpress

2 months / medicalxpress

2 months / medicalxpress

2 months / medicalxpress


Back to Top / Tue, June 9, 2026, 10:21 am / permalink 25044 / 28 stories in 2 months /



Blog Post
An Ebola outbreak centered in eastern Democratic Republic of the Congo has surpassed 100 confirmed deaths as cases continue to rise faster than response efforts. Key facts - Official tallies: about 550 confirmed cases and 101 confirmed deaths (CDC report cited June 7). News outlets report at least 100 deaths less than a month after the outbreak was declared. - Modeling by U.S. health officials warns that, without much stronger isolation of infectious people and improved public‑health measures, the outbreak could grow to 20,000 cases or more. - The virus circulating is the Bundibugyo strain, which has a reported fatality rate of roughly 30–50%; there is currently no approved vaccine specifically for this strain. Why the outbreak is expanding - Response capacity is lagging behind transmission. Public‑health experts say vaccines alone will not stop spread unless combined with robust surveillance, rapid contact tracing, safe patient isolation and sustained community engagement. - Community resistance and insecurity are complicating interventions: incidents reported include the burning of an Ebola treatment facility in Mongbwalu, confrontations around burial practices and reports of police firing warning shots. Vaccine and preparedness efforts - Multiple groups are racing to develop and test vaccines. Some candidates could begin human testing within two to three months, while more advanced candidates might take up to nine months to reach trials. - Regional and international agencies have begun coordinated planning: the Africa CDC and WHO launched a joint continental preparedness and response plan to support affected countries. Bottom line The outbreak has crossed the 100‑death threshold and is outpacing current response capacity. Experts and modelers say urgent strengthening of surveillance, contact tracing, isolation and community engagement — alongside accelerated vaccine development — will be needed to prevent much larger spread.

Flesh-Eating New World Screwworm Confirmed in Texas, Posing Risk to U.S. Cattle for First Time in Decades

discovermagazine - Learn about the New World screwworm, a parasitic fly that has just been confirmed in the U.S., and find out what's being done to stop its spread.

AI Summary: Authorities have confirmed the return of the New World screwworm to Texas, a flesh‑eating fly larva that can devastate livestock. Officials are ramping up surveillance, trapping and containment measures to protect cattle herds and limit economic damage; human infections remain rare but the agricultural hit could be substantial.

2 months / discovermagazine

2 months / discovermagazine

2 months / livescience




What to know about new Ebola outbreak that has killed 65 people in Congo

medicalxpress - Africa's top public health body has confirmed a new Ebola outbreak in Congo's Ituri province, the 17th since the disease first emerged in the country in 1976.

AI Summary: Health authorities have confirmed a fresh Ebola outbreak in a remote province of the Democratic Republic of Congo that has killed roughly 65 people. Public-health teams are scrambling to trace contacts, ramp up surveillance, and deploy vaccines and treatments amid logistical and security hurdles. Containment hinges on rapid mobilization and local cooperation.


Confirmed Ituri outbreak: cases, deaths and on-the-ground response

3 months / medicalxpress

3 months / abcnews

3 months / medicalxpress

3 months / abcnews


Vaccine shortages, high lethality and push for new vaccines

3 months / newscientist

3 months / medicalxpress

3 months / medicalxpress


WHO declares global health emergency; international response underway

3 months / medicalxpress

3 months / abcnews

3 months / medicalxpress

3 months / medicalxpress


All Other Stories

3 months / livescience

3 months / medicalxpress

3 months / newscientist

3 months / bbc

3 months / bbc

3 months / medicalxpress

3 months / medicalxpress

3 months / abcnews

3 months / medicalxpress

3 months / abcnews

3 months / medicalxpress

3 months / abcnews

3 months / abcnews

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / bbc

3 months / abcnews

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / livescience

3 months / medicalxpress


Back to Top / Sat, May 16, 2026, 12:21 am / permalink 23870 / 52 stories in 3 months /



Amazon Pharmacy to offer home delivery for Novo Nordisk's Ozempic pill

fiercehealthcare - Amazon Pharmacy will make Novo Nordisk's Ozempic pill available for home delivery, the company announced Thursday.

AI Summary: Amazon Pharmacy is expanding access to Novo Nordisk’s oral semaglutide (Ozempic) by adding the pill to same‑day prescription kiosks and rolling out home delivery, widening availability beyond clinics and specialty pharmacies. Consumers will now find GLP‑1s via retail logistics — because apparently weight‑loss pills need shipping and curb‑side convenience too.


Clinical research and future GLP-1 treatments

3 months / medicalxpress

3 months / oncodaily


Payers and companies reshape access: Medicare, employers, retail programs

3 months / fiercehealthcare

3 months / fiercehealthcare

3 months / medicalxpress


Retail rollout: Amazon kiosks and pharmacy delivery for Ozempic

3 months / fiercehealthcare


All Other Stories

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress


Back to Top / Thu, May 7, 2026, 8:23 pm / permalink 23429 / 15 stories in 3 months /



6 Things to Know About Medtronic’s Cyberattack

Katie Adams / medcitynews - Medtronic suffered a cyberattack on its corporate IT systems. The incident highlights growing cybersecurity risks in the medtech sector, with cybergangs increasingly using phishing and other human-engineering tactics to gain access to data.The post 6 Thin…

AI Summary: Medtronic reported an IT systems breach following a cyberattack, prompting an internal probe and operational mitigation efforts. The company is assessing clinical and supply impacts, notifying stakeholders, and coordinating with cybersecurity authorities — a reminder that even medtech giants are not immune to the digital snarls that can ripple through patient care and profits.


Back to Top / Sat, May 2, 2026, 8:21 pm / permalink 23143 / 8 stories in 3 months /



Court restricts abortion access across US by blocking mailing of mifepristone

abcnews - A federal appeals court has restricted access to one of the most common means of abortion in the U.S. by blocking the mailing of mifepristone

AI Summary: A federal appeals court has imposed new limits on distribution of mifepristone, blocking mail-order shipments and narrowing telehealth-based prescribing. The decision immediately complicates access for patients and clinicians who rely on remote care and pharmacy delivery, forcing last‑minute logistical changes, increased travel, and swift legal and policy responses as providers scramble to adapt.


Appeals court halts mail and telehealth access

3 months / abcnews


Clinical pivots and drug alternatives amid disruptions

3 months / abcnews


Supreme Court temporarily restores mail access

3 months / medicalxpress

3 months / fiercehealthcare


All Other Stories

3 months / npr / Ryan Benk


Back to Top / Sat, May 2, 2026, 7:21 am / permalink 23121 / 14 stories in 3 months /



WHO approves first malaria treatment for infants

medicalxpress - The World Health Organization announced Friday that it had given prequalification approval to a malaria treatment for newborns and infants for the first time.

AI Summary: The World Health Organization has cleared the first malaria treatment specifically for infants, granting prequalification that paves the way for broader procurement and use in endemic countries. Regulators' sign-off targets a vulnerable age group long underserved by effective pediatric therapies, potentially speeding distribution through global health channels and donor programs.

3 months / medicalxpress

4 months / medicalxpress




Back to Top


SUPPLYCHAIN Heatmap


90 days, weeks are vertical, left is older; hover for info, click to see that day's coverage.


StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Oncology, Cybersecurity, Animal Health, Pediatric Oncology and look for the RSS link.


NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.